260 related articles for article (PubMed ID: 18559695)
1. Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin.
Medina MW; Gao F; Ruan W; Rotter JI; Krauss RM
Circulation; 2008 Jul; 118(4):355-62. PubMed ID: 18559695
[TBL] [Abstract][Full Text] [Related]
2. The role of HMGCR alternative splicing in statin efficacy.
Medina MW; Krauss RM
Trends Cardiovasc Med; 2009 Jul; 19(5):173-7. PubMed ID: 20005478
[TBL] [Abstract][Full Text] [Related]
3. HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism.
Yu CY; Theusch E; Lo K; Mangravite LM; Naidoo D; Kutilova M; Medina MW
Hum Mol Genet; 2014 Jan; 23(2):319-32. PubMed ID: 24001602
[TBL] [Abstract][Full Text] [Related]
4. Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment.
Krauss RM; Mangravite LM; Smith JD; Medina MW; Wang D; Guo X; Rieder MJ; Simon JA; Hulley SB; Waters D; Saad M; Williams PT; Taylor KD; Yang H; Nickerson DA; Rotter JI
Circulation; 2008 Mar; 117(12):1537-44. PubMed ID: 18332269
[TBL] [Abstract][Full Text] [Related]
5. Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13.
Burkhardt R; Kenny EE; Lowe JK; Birkeland A; Josowitz R; Noel M; Salit J; Maller JB; Pe'er I; Daly MJ; Altshuler D; Stoffel M; Friedman JM; Breslow JL
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2078-84. PubMed ID: 18802019
[TBL] [Abstract][Full Text] [Related]
6. Role of rs3846662 and HMGCR alternative splicing in statin efficacy and baseline lipid levels in familial hypercholesterolemia.
Leduc V; Bourque L; Poirier J; Dufour R
Pharmacogenet Genomics; 2016 Jan; 26(1):1-11. PubMed ID: 26466344
[TBL] [Abstract][Full Text] [Related]
7. Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin.
Mangravite LM; Medina MW; Cui J; Pressman S; Smith JD; Rieder MJ; Guo X; Nickerson DA; Rotter JI; Krauss RM
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1485-92. PubMed ID: 20413733
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M
PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674
[TBL] [Abstract][Full Text] [Related]
9. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
10. Association of the functional variant in the 3-hydroxy-3-methylglutaryl-coenzyme a reductase gene with low-density lipoprotein-cholesterol in Japanese.
Hiura Y; Tabara Y; Kokubo Y; Okamura T; Goto Y; Nonogi H; Miki T; Tomoike H; Iwai N
Circ J; 2010 Mar; 74(3):518-22. PubMed ID: 20145341
[TBL] [Abstract][Full Text] [Related]
11. The relationship between HMGCR genetic variation, alternative splicing, and statin efficacy.
Medina MW
Discov Med; 2010 Jun; 9(49):495-9. PubMed ID: 20587337
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer.
Lipkin SM; Chao EC; Moreno V; Rozek LS; Rennert H; Pinchev M; Dizon D; Rennert G; Kopelovich L; Gruber SB
Cancer Prev Res (Phila); 2010 May; 3(5):597-603. PubMed ID: 20403997
[TBL] [Abstract][Full Text] [Related]
13. RP1-13D10.2 Is a Novel Modulator of Statin-Induced Changes in Cholesterol.
Mitchel K; Theusch E; Cubitt C; Dosé AC; Stevens K; Naidoo D; Medina MW
Circ Cardiovasc Genet; 2016 Jun; 9(3):223-30. PubMed ID: 27071970
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors.
Bisgaier CL; Essenburg AD; Auerbach BJ; Pape ME; Sekerke CS; Gee A; Wölle S; Newton RS
J Lipid Res; 1997 Dec; 38(12):2502-15. PubMed ID: 9458274
[TBL] [Abstract][Full Text] [Related]
15. A novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) splice variant with an alternative exon 1 potentially encoding an extended N-terminus.
Stormo C; Kringen MK; Grimholt RM; Berg JP; Piehler AP
BMC Mol Biol; 2012 Sep; 13():29. PubMed ID: 22989091
[TBL] [Abstract][Full Text] [Related]
16. RHOA is a modulator of the cholesterol-lowering effects of statin.
Medina MW; Theusch E; Naidoo D; Bauzon F; Stevens K; Mangravite LM; Kuang YL; Krauss RM
PLoS Genet; 2012; 8(11):e1003058. PubMed ID: 23166513
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells.
Villanueva JA; Sokalska A; Cress AB; Ortega I; Bruner-Tran KL; Osteen KG; Duleba AJ
J Clin Endocrinol Metab; 2013 Mar; 98(3):E455-62. PubMed ID: 23386644
[TBL] [Abstract][Full Text] [Related]
18. Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy.
Poduri A; Khullar M; Bahl A; Sehrawat BS; Sharma Y; Talwar KK
DNA Cell Biol; 2010 Oct; 29(10):629-37. PubMed ID: 20578904
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin increases expression of low-density lipoprotein receptor mRNA in human circulating mononuclear cells.
Pocathikorn A; Taylor RR; Mamotte CD
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):471-6. PubMed ID: 19930424
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study.
Simon JA; Lin F; Hulley SB; Blanche PJ; Waters D; Shiboski S; Rotter JI; Nickerson DA; Yang H; Saad M; Krauss RM
Am J Cardiol; 2006 Mar; 97(6):843-50. PubMed ID: 16516587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
